The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lewis David L. since year 2005.
The trader's CIK number is 1595838.
At the time of the last reporting, Lewis David L. was the Chief Scientific Officer of Arrowhead Pharmaceuticals, Inc. .
(stock ticker symbol ARWR).
See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-01-05||ARWR||Arrowhead Pharmaceuticals, Inc.||Option Ex||15,000||2.01||30,149|
|2015-01-05||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||15,000||8.01||120,105|
|2014-09-30||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||15,000||15.02||225,345|
|2014-09-30||ARWR||Arrowhead Pharmaceuticals, Inc.||Option Ex||15,000||2.01||30,149|
|2014-01-02||ARWR||Arrowhead Pharmaceuticals, Inc.||Sale||15,000||10.29||154,290|
|2014-01-02||ARWR||Arrowhead Pharmaceuticals, Inc.||Option Ex||15,000||4.14||62,054|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lewis David L. (Chief Scientific Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.